294 related articles for article (PubMed ID: 38068715)
1. The Use of Soy Isoflavones in the Treatment of Prostate Cancer: A Focus on the Cellular Effects.
Van der Eecken H; Joniau S; Berghen C; Rans K; De Meerleer G
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068715
[TBL] [Abstract][Full Text] [Related]
2. Soy isoflavones and prostate cancer: a review of molecular mechanisms.
Mahmoud AM; Yang W; Bosland MC
J Steroid Biochem Mol Biol; 2014 Mar; 140():116-32. PubMed ID: 24373791
[TBL] [Abstract][Full Text] [Related]
3. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
4. Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone.
Dong X; Xu W; Sikes RA; Wu C
Food Chem; 2013 Dec; 141(3):1923-33. PubMed ID: 23870911
[TBL] [Abstract][Full Text] [Related]
5. Soy-derived isoflavones exert opposing actions on Guinea pig ventricular myocytes.
Liew R; Williams JK; Collins P; MacLeod KT
J Pharmacol Exp Ther; 2003 Mar; 304(3):985-93. PubMed ID: 12604673
[TBL] [Abstract][Full Text] [Related]
6. Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.
Mathey J; Mardon J; Fokialakis N; Puel C; Kati-Coulibaly S; Mitakou S; Bennetau-Pelissero C; Lamothe V; Davicco MJ; Lebecque P; Horcajada MN; Coxam V
Osteoporos Int; 2007 May; 18(5):671-9. PubMed ID: 17333448
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the role of isoflavones in prostate cancer.
Ahmad A; Biersack B; Li Y; Bao B; Kong D; Ali S; Banerjee S; Sarkar FH
AAPS J; 2013 Oct; 15(4):991-1000. PubMed ID: 23824838
[TBL] [Abstract][Full Text] [Related]
8. Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells.
Szliszka E; Krol W
Oncol Rep; 2011 Sep; 26(3):533-41. PubMed ID: 21637922
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women.
Gleason CE; Carlsson CM; Barnet JH; Meade SA; Setchell KD; Atwood CS; Johnson SC; Ries ML; Asthana S
Age Ageing; 2009 Jan; 38(1):86-93. PubMed ID: 19054783
[TBL] [Abstract][Full Text] [Related]
10. Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.
Jackman KA; Woodman OL; Sobey CG
Curr Med Chem; 2007; 14(26):2824-30. PubMed ID: 18045128
[TBL] [Abstract][Full Text] [Related]
11. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
[TBL] [Abstract][Full Text] [Related]
12. Daidzein effect on hormone refractory prostate cancer in vitro and in vivo compared to genistein and soy extract: potentiation of radiotherapy.
Singh-Gupta V; Zhang H; Yunker CK; Ahmad Z; Zwier D; Sarkar FH; Hillman GG
Pharm Res; 2010 Jun; 27(6):1115-27. PubMed ID: 20309614
[TBL] [Abstract][Full Text] [Related]
13. S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway.
Lu Z; Zhou R; Kong Y; Wang J; Xia W; Guo J; Liu J; Sun H; Liu K; Yang J; Mi M; Xu H
Curr Cancer Drug Targets; 2016; 16(5):455-65. PubMed ID: 26638886
[TBL] [Abstract][Full Text] [Related]
14. Lack of combination effects of soy isoflavones and taxane chemotherapy of castration-resistant prostate cancer.
Eskra JN; Schlicht MJ; Bosland MC
Prostate; 2019 Feb; 79(2):223-233. PubMed ID: 30345530
[TBL] [Abstract][Full Text] [Related]
15. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.
Mizunuma H; Kanazawa K; Ogura S; Otsuka S; Nagai H
Oncology; 2002; 62(1):78-84. PubMed ID: 11810047
[TBL] [Abstract][Full Text] [Related]
16. Human CYP3A4 and murine Cyp3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner.
Li Y; Ross-Viola JS; Shay NF; Moore DD; Ricketts ML
J Nutr; 2009 May; 139(5):898-904. PubMed ID: 19297428
[TBL] [Abstract][Full Text] [Related]
17. Dietary genistein and equol (4', 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia.
Ma Y; Sullivan JC; Schreihofer DA
Am J Physiol Regul Integr Comp Physiol; 2010 Sep; 299(3):R871-7. PubMed ID: 20631292
[TBL] [Abstract][Full Text] [Related]
18. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
19. Soy isoflavones and cancer prevention.
Sarkar FH; Li Y
Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
[TBL] [Abstract][Full Text] [Related]
20. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
Raschke M; Wähälä K; Pool-Zobel BL
Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
